Analysis: Experts mixed on Pfizer future (UPI)

WASHINGTON, July 21 (UPI) -- Pfizer, the world's largest pharmaceutical company, posted a solid second quarter that was driven by a strong performance from its cholesterol-lowering drug Lipitor, but analysts are split on whether the company can continue achieving these kinds of figures in the future.

[News Source]